Status:
UNKNOWN
Efficacy of Ivermectin in COVID-19
Lead Sponsor:
Combined Military Hospital, Pakistan
Conditions:
COVID
Eligibility:
All Genders
15-65 years
Phase:
NA
Brief Summary
It is a randomized controlled trial to assess the efficacy of Ivermectin in COVID-19. Patient recruited will be assigned to two groups one group will be given ivermectin with standard chloroquine regi...
Detailed Description
INTERVENTION It will be a randomized controlled trial which will be done on COVID-19 patients proven by PCR fulfilling the criteria (asymptomatic/mild to moderate severity). They will be divided into ...
Eligibility Criteria
Inclusion
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, aged 15 to 65 years
- In good general health with no or mild to moderate symptoms of Corona virus disease
- PCR positive for SARS-Cov-2.
- Ability to take oral medication and be willing to adhere to the drug intake regimen
Exclusion
- Severe symptoms likely attributed to Cytokine Release Storm.
- Malignant diseases, diabetes mellitus, chronic kidney disease and cirrhosis liver with CPT class B or C.
Key Trial Info
Start Date :
April 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04392713
Start Date
April 15 2020
End Date
July 1 2020
Last Update
May 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Combined Military Hospital Lahore
Lahore, Punjab Province, Pakistan